Evidence map›Paper›PMID 32807820›Full record

ArticleScientific reports2020

DNA-damage and cell cycle arrest initiated anti-cancer potency of super tiny carbon dots on MCF7 cell line.

Sinem Şimşek, Ayça Aktaş Şüküroğlu, Derya Yetkin, Belma Özbek, Dilek Battal, Rükan Genç

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. A Strategic Review on Carbon Quantum Dots for Cancer-Diagnostics and Treatment.Frontiers in bioengineering and biotechnology · 2022
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Sinem Şimşek *Department of Chemical Engineering, Yıldız Technical University, 34210, Esenler, Istanbul, Turkey.
Ayça Aktaş Şüküroğlu *Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Gazi University, 06330, Ankara, Turkey.
Derya YetkinAdvanced Technology Research and Application Center, Mersin University, 33343, Mersin, Turkey.
Belma ÖzbekDepartment of Chemical Engineering, Yıldız Technical University, 34210, Esenler, Istanbul, Turkey.
Dilek BattalDepartment of Pharmaceutical Toxicology, Faculty of Pharmacy, Mersin University, 33169, Yenişehir, Mersin, Turkey. dilekbattal@mersin.edu.tr.
Rükan GençDepartment of Chemical Engineering, Faculty of Engineering, Mersin University, 33343, Yenişehir, Mersin, Turkey. rgenc@mersin.edu.tr.
Mersin Üniversitesi · TRYıldız Technical University · TRGazi University · TRNear East University · CY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While carbon-based materials have spearheaded numerous breakthroughs in biomedicine, they also have procreated many logical concerns on their overall toxicity. Carbon dots (CDs) as a respectively new member have been extensively explored in nucleus directed delivery and bioimaging due to their intrinsic fluorescence properties coupled with their small size and surface properties. Although various in vitro/in vivo studies have shown that CDs are mostly biocompatible, sufficient information is lacking regarding genotoxicity of them and underlying mechanisms. This study aims to analyze the real-time cytotoxicity of super tiny CDs (2.05 ± 0.22 nm) on human breast cancer cells (MCF7) and human primary dermal fibroblast cell cultures (HDFa) by xCELLigence analysis system for further evaluating their genotoxicity and clastogenicity to evaluate the anti-tumor potential of CDs on breast adenocarcinoma. As combined with flow cytometry studies, comet assay and cytokinesis-block micronucleus assay suggest that the CDs can penetrate to the cell nuclei, interact with the genetic material, and explode DNA damage and G0/G1 phase arrest in cancer cells even at very low concentrations (0.025 ppm) which provide a strong foundation for the design of potentially promising CD-based functional nanomaterials for DNA-damage induced treatment in cancer therapy.

Indexed as

Cell Cycle CheckpointsDNA DamageAntineoplastic AgentsCarbonDynamic Light ScatteringHumansHydrodynamicsMCF-7 CellsMicronucleus TestsMutagensParticle SizePhotoelectron SpectroscopyQuantum DotsSpectroscopy, Fourier Transform InfraredTime FactorsAntineoplastic AgentsCarbonMutagens

Identifiers

PMID32807820
PMCPMC7431908
OpenAlexW3049414433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.